Inspire Medical Systems, Inc. — Form 10-Q
Filed November 2, 2026 · analyzed by the Periodic Agent
10-Q
— Neutral
significance 8/100
What the filing says
Timothy P. Herbert (CEO/Chairperson) and Matthew J. Osberg (CFO) signed standard Sarbanes-Oxley certifications on November 2, 2026 for the Q3 ended September 30, 2026. Both officers attest that disclosure controls, internal controls over financial reporting are effective, and no material weaknesses or fraud were identified. No specific financial metrics, operational changes, or material events are disclosed in these certification exhibits.
Why this rating
Routine SOX certifications with no disclosed control deficiencies or fraud. Standard quarterly filing mechanics; no operational or financial substance disclosed here.
See more from November 2, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.